Search

everythinglearnresearchcommunity

for

Search:↓

Curcumin spanlastics are the most effective for cancer therapy due to their strong antimicrobial, antioxidant, and antitumor effects.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

Prunus mira Koehne is valuable for hair growth and has potential for sustainable use, but needs more research and conservation.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Sulfasalazine might cause hair loss, especially in women, and stopping it can reverse the hair loss.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

The new composite material is safe and has anticoagulant properties.

Finasteride effectively treats male hair loss, improving growth and density.

Non-drug therapies show promise for hair regrowth but need more research.

Minoxidil effectively lowers blood pressure with few side effects.

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

Electrospun nanofibers might be a promising new treatment for hair loss.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Clascoterone 1% cream is a promising new treatment for acne.

Hair analysis can offer clues about a person, but individual differences limit making precise identifications.

Improved Finasteride delivery for hair loss treatment.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

The document explains various skin conditions in cats and how to diagnose and treat them.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Rituximab can cause skin issues, but baricitinib may help improve them.

Targeting hair follicles can improve skin treatments and reduce side effects.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.